Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood. [electronic resource]
Producer: 20091022Description: 2541-51 p. digitalISSN:- 1078-0432
- CD8-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- immunology
- Histocompatibility Antigens Class I -- metabolism
- Humans
- Immunologic Memory
- Lymph Nodes -- immunology
- Lymphocyte Activation
- Lysosomal Membrane Proteins -- analysis
- Melanoma -- immunology
- Membrane Glycoproteins -- immunology
- Sentinel Lymph Node Biopsy
- gp100 Melanoma Antigen
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.